CAMKV kinase drives neuroblastoma growth and acts as a novel therapeutic target
This work identifies CaM kinase-like vesicle-associated protein (CAMKV) as a MYCN/MYC-regulated effector of NB pathogenesis and establishes CAMKV as a central signaling hub that coordinates metabolic and proliferative pathways.